Results 31 to 40 of about 12,656 (216)
Hyperhidrosis post-treatment questionnaire.
, 2023 The use of reconstituted and frozen left-over botulinum toxin A, for treatment of patients with axillary hyperhidrosis seems to be common practice in healthcare.
Antonia Boman (17549613) +3 more
core +1 more source
Current treatment options for craniofacial hyperhidrosis [PDF]
Jornal Vascular Brasileiro, 2020 Hyperhidrosis (HH) is characterized by sweating exceeding the amount necessary to meet the thermal regulation and physiological needs of the body. Approximately 9.41% of individuals with HH have craniofacial hyperhidrosis (FH).
Nelson Wolosker +4 more
doaj +1 more source
Hyperhidrosis pre-treatment questionnaire.
, 2023 The use of reconstituted and frozen left-over botulinum toxin A, for treatment of patients with axillary hyperhidrosis seems to be common practice in healthcare.
Antonia Boman (17549613) +3 more
core +1 more source
American Journal of Medical Genetics Part A, EarlyView.ABSTRACT Heterozygous germline variants in CBL disrupt its function as a negative regulator of the Ras/MAPK pathway, classically predisposing to Juvenile myelomonocytic leukemia (JMML) and moyamoya. We describe two affected siblings carrying a paternally inherited CBL variant (c.1210 T> C, p.
Michal Bar‐Hakim +12 more
wiley +1 more source
Clinics, 2008 INTRODUCTION: Level T4 video-assisted thoracoscopic sympathectomy proved superior to T3-T4 treatment for controlling axillary hyperhidrosis at the initial and six-month follow-ups of these patients.
Marco Antonio S. Munia +4 more
doaj +1 more source
Scientific Reports, 2021 Compensatory hyperhidrosis is the leading cause of patients' dissatisfaction after thoracic sympathicotomy. The study aimed to reduce compensatory hyperhidrosis to increase patients’ satisfaction.
Vicente Vanaclocha +6 more
doaj +1 more source
Development of a nalmefene formulation suitable for a community‐use auto‐injector
British Journal of Clinical Pharmacology, EarlyView.Aim Time to onset of reversal is critical when treating opioid‐induced respiratory depression and hypoxia. This study aimed to develop a formulation of the opioid antagonist nalmefene with an increased absorption rate and reduced time to onset of reversal following intramuscular administration. Methods Several absorption enhancers were screened in rats,
Alessandra Cipriano +6 more
wiley +1 more source
Evaluation of Extended Thoracoscopic Sympathectomy in the Treatment of Primary Palmar Hyperhidrosis [PDF]
Al-Azhar International Medical Journal, 2000 Background: Management of palmar and axillary hyperhidrosis is contingent upon the sympathetic denervation of the specific area afflicted, typically corresponding to the innervation provided by thoracic sympathetic ganglia numbers 2, 3, and 4.
Mahsoub Amin, Ahmed Daha, Ahmed Elgmal
doaj +1 more source
Nail Disorders in Systemic Conditions
JEADV Clinical Practice, EarlyView.ABSTRACT Nail findings in children can be indicative of an underlying systemic disease. Many of these findings are seen in multiple entities and are not specific to one disease. The importance of specifically examining for these nail changes cannot be overstated.
Jane Sanders Bellet
wiley +1 more source
Hyperhidrosis and the risk of being treated for skin infections
, 2021 A few studies have described an increased prevalence of skin infections in individuals with hyperhidrosis compared to others. However, it remains uncertain whether hyperhidrosis is an independent risk factor for skin infections.
Kristina S. Ibler (10912568) +12 more
core +2 more sources